Moreover, drug treatment downregulates FOXM1 expression at both the transcriptional and posttranslational levels in the sensitive breast cancer, whereas FOXM1 expression remains at high levels in the resistant cells13,22,26,27,29,34. The gene discussed is FOXM1; the disease is breast carcinoma.